Industry Insight
Information, Observation & Analysis
Therapeutics Articles
Findings suggest CSL112 can boost cholesterol efflux capacity in patients with impaired endogenous HDL function. Encouragingly, several studies have documented its ability to reduce atherosclerotic plaque volume.
Using nutrition to benefit health through the care and feeding of genes, though still in its infancy, is an exciting field of study seeing exponential growth.
A growing body of evidence suggests known pharmacologic properties of human albumin may contribute to reducing the risk of a range of cirrhosis complications, including bacterial sepsis, irreversible renal injury and death.
A host of programs continue to be implemented in the United States and globally to address antibiotic-resistant illnesses.
Can marijuana be used as an adjunct to or substitute for opioids in the treatment of chronic pain
to potentially alleviate the opioid crisis?
Once thought to be a useless byproduct, umbilical cord blood now treats more than 80 diseases, and it may soon be used to treat more.
Potentially curative gene therapy is in the works for hemophilia.
Hereditary angioedema is a rare genetic disease for which replacement therapy provides safe and highly effective treatment.
Researchers are taking a closer look at intravenous immune globulin for its potential to stop the progression of multiple complex conditions from lupus to multiple sclerosis.
Many years after the first products were introduced in the late 1990s, the need for fibrin sealants continues to increase.
Antibiotics are the most commonly prescribed drugs worldwide. But now, widespread antimicrobial resistance caused by environments, hosts and overmedication may soon be the demise of these "wonder drugs."
Studies are shedding light on this long-misunderstood and devastating condition that may soon have approved treatments to help prolong cancer patients’ lives.